New England Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

New England Securities’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$642K	Buy	10,338 +411	+4%	+$23.4K	0.23%	116
2014 Q3	$516K	Sell	9,927 -1,203	-11%	-$61.3K	0.18%	137
2014 Q2	$571K	Buy	11,130 +1,710	+18%	+$77.1K	0.2%	135
2014 Q1	$447K	Buy	9,420 +174	+2%	+$8.91K	0.17%	146
2013 Q4	$401K	Buy	9,246 +1,203	+15%	+$49.8K	0.17%	161
2013 Q3	$346K	Sell	8,043 -33	-0.4%	-$1.34K	0.17%	150
2013 Q2	$281K	Buy	+8,076	New	+$284K	0.19%	127

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

New England Securities's XBI Position: Q4 2014 in Review

New England Securities increased its State Street SPDR S&P Biotech ETF (XBI) stake by 4.1% in Q4 2014, buying an estimated $23.4K and bringing the position to 10,338 shares worth $642K. The position accounts for 0.23% of the portfolio, ranked #116.

New England Securities first reported a position in XBI in Q2 2013 and has held it in 7 quarters since. 146 funds tracked by Wall St. Rank hold XBI as of Q4 2014.

New England Securities held 10,338 shares of State Street SPDR S&P Biotech ETF worth $642K as of Q4 2014.
New England Securities bought 411 State Street SPDR S&P Biotech ETF shares in Q4 2014, an estimated $23.4K.
State Street SPDR S&P Biotech ETF made up 0.23% of New England Securities's portfolio in Q4 2014, its #116 holding.
New England Securities first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 7 quarters since.
146 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.